Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS

by Désirée van der Heijde, Robert Landewé
Published 2019-11-01

A single determination of C-reactive protein does not suffice to declare a patient with a diagnosis of axial spondyloarthritis ‘CRP-negative’

by Robert Landewé, Tommi Nurminen, Owen Davies, Dominique Baeten
Published 2018-09-01

Prevalence of Self-Reported Spondyloarthritis Features in a Cohort of Patients with Inflammatory Bowel Disease

by Carmen Stolwijk, Marieke Pierik, Robert Landewé, Ad Masclee, Astrid van Tubergen
Published 2013-01-01

Robust analyses for radiographic progression in rheumatoid arthritis

by Robert Landewé, Désirée van der Heijde, Yun-fei Chen, Luna Sun, Mo Daojun
Published 2023-04-01

Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort

by Sofia Ramiro, Robert Landewé, Désirée van der Heijde, Maxime Dougados, Annelies Boonen, Jürgen Braun, Uta Kiltz, Imke Redeker
Published 2023-11-01

Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthrit...

by Miranda van Lunteren, Alexandre Sepriano, Robert Landewé, Joachim Sieper, Martin Rudwaleit, Désirée van der Heijde, Floris van Gaalen
Published 2018-08-01

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

by Casper Webers, Carmen Stolwijk, Olga Schiepers, Thea Schoonbrood, Astrid van Tubergen, Robert Landewé, Désirée van der Heijde, Annelies Boonen
Published 2020-09-01

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome

by Tom van Kraaij, Rémy Mostard, Sofia Ramiro, Cesar Magro Checa, Christel van Dongen, Eric HJ van Haren, Jacqueline Buijs, Robert Landewé
Published 2020-04-01

The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study

by Pauline Bakker, Anna Moltó, Adrien Etcheto, Filip Van den Bosch, Robert Landewé, Floris van Gaalen, Maxime Dougados, Désirée van der Heijde
Published 2017-05-01

Role of vertebral corner inflammation and fat deposition on MRI on syndesmophyte development detected on whole spine low-dose CT scan in radiographic axial spondyloarthritis

by Sofia Ramiro, Robert Landewé, Désirée van der Heijde, Xenofon Baraliakos, Monique Reijnierse, Alexandre Sepriano, Floris van Gaalen, Rosaline van den Berg, Rosalinde Stal
Published 2022-11-01

Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts

by Zineb Ez-Zaitouni, Andrea Hilkens, Laure Gossec, Inger Jorid Berg, Robert Landewé, Roberta Ramonda, Maxime Dougados, Désirée van der Heijde, Floris van Gaalen
Published 2017-05-01

Distinction and prognosis of early arthritis phenotypes: an analysis in three European cohorts

by Sofia Ramiro, Robert Landewé, Annette van der Helm-van Mil, Alexandre Sepriano, Bernard Combe, Alison Kent, Dirkjan van Schaardenburg, Bastiaan van Dijk, Elsa Mateus
Published 2023-10-01

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd s...

by Robert Landewé, Désirée van der Heijde, Atul Deodhar, Martin Rudwaleit, Lianne S Gensler, Walter P Maksymowych, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri
Published 2022-03-01

Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE

by Robert Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip Van den Bosch, Karl Gaffney, Lars Bauer, Bengt Hoepken, Natasha de Peyrecave, Karen Thomas, Lianne S. Gensler
Published 2020-06-01

Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTUR...

by Robert Landewé, Désirée van der Heijde, Philip J Mease, Hasan Tahir, Shephard Mpofu, Luminita Pricop, Proton Rahman, Atul Singhal, Sandra Navarra, Aimee Readie, Elke Boettcher, Eumorphia Maria Delicha
Published 2021-08-01

Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial

by Sofia Ramiro, Robert Landewé, Désirée van der Heijde, Xenofon Baraliakos, Monique Reijnierse, Juergen Braun, Pedro M Machado, Alexandre Sepriano, Floris A van Gaalen, Rosaline van den Berg, Rosalinde Stal
Published 2023-08-01

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Man...

by Monika Hebeisen, Raphael Micheroli, Almut Scherer, Xenofon Baraliakos, Manouk de Hooge, Désirée van der Heijde, Robert Landewé, Kristina Bürki, Michael J Nissen, Burkhard Möller, Pascal Zufferey, Pascale Exer, Adrian Ciurea
Published 2020-01-01

Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBAR...

by Walter P. Maksymowych, Pascal Claudepierre, Manouk de Hooge, Robert G. Lambert, Robert Landewé, Anna Molto, Désirée van der Heijde, Jack F. Bukowski, Heather Jones, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Maxime Dougados
Published 2021-01-01

Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international survey

by Robert Landewé, Kim Lauper, Theodora P M Vliet Vlieland, Uta Kiltz, Jette Primdahl, Ricardo J O Ferreira, Mwidimi Ndosi, Manouk de Hooge, Tue Wenzel Kragstrup, Souzi Makri, Luis Fernando Perez-Garcia, Elsa Frãzao-Mateus, Peter Boyd
Published 2024-06-01

Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III...

by Robert Landewé, Joseph F Merola, Laure Gossec, Frank Behrens, Ana-Maria Orbai, Philip J Mease, Iain B McInnes, Yoshiya Tanaka, Dafna D Gladman, Laura C Coates, Alice B Gottlieb, Vishvesh Shende, Jason Coarse, Christopher T Ritchlin, Richard B Warren, Akihiko Asahina, Barbara Ink, Rajan Bajracharya
Published 2024-02-01